In 2014, at the age of 14, Molly was diagnosed with a rare type of acute lymphoblastic leukemia (ALL) known as hypodiploid ALL. Her only chance for survival was a bone marrow transplant. Fortunately, Molly's older brother was a match. After the procedure, Molly stayed in the hospital for 42 days, including Christmas and New Year's, only leaving her room for full-body radiation treatments.
"When Molly's pain was becoming unbearable, the doctors, nurses, child life specialists, and volunteers worked together to make her more comfortable and happy," says her mom, Christy. "When the day finally arrived to leave the hospital, there was a celebration of noise makers, bubbles, and cheers all the way down the hallway."
As a follow-up to her transplant, Molly was part of a groundbreaking clinical trial for T-cell therapy, which can prevent infections and relapses with few side effects.
"They took my brother's T cells and trained them in a lab to fight cancer cells, and then they put them back into my body," explains Molly, now cancer- free and grateful for the chance to return to things that she loves, like competitive dancing.
Children's National is a leader in T-cell therapy, one of the most exciting advances in cancer treatment. The generosity of our supporters ensures that Children's National can stay at the forefront of innovative research, like T-cell therapy, and help more young people like Molly grow up stronger